Clinical Trial Update: Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of LNZ101 (aceclidine/brimonidine) and LNZ100 (aceclidine) for presbyopia has completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia
• Refractive Errors

Drugs mentioned

• LNZ100 (Aceclidine)
• LNZ101 (Aceclidine/Brimonidine)

Snippet

Sponsor: LENZ Therapeutics, Inc | Conditions: Presbyopia, Refractive Errors | Phase 2 | Status: COMPLETED | Results posted: 2024-09-05